Junk DNA is not junk after all Recently, scientists at the University of Oxford have discovered that ‘junk’ genetic material can switch off cancer tumours, preventing them from growing. By using RNA to switch off a gene involved in controlling cell division, Oxford University scientists may have found a role for RNA in developing new [...]
Filed under: bacteria, biodefense, bioinformatics, bioinformatics blog, clinical diagnostics, clinical microarray, digital, DNA, DNA microarray, drug development, drug discoverry, epigenetics, gene expression, genetics, genotyping, microaray blog, microarray, microarray analysis, microarray for clinical diagnostics, Next Generation of DNA and RNA Microarrays, outsource, personalized medicine, Pharmacogenomics, RNA, RNA microarray | 1 Comment »
